VR Logo

Windlas Biotech Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

48 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2018 download pdf director's report download pdf auditor's report download pdf account notes
2017 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2016 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2001

Chairman: Vivek Dhariwal

Managing Director: Hitesh Windlass

Group: --

Listing: NSE: WINDLAS, BSE: 543329

Headquarters: Dehradun, Uttarakhand

Website: www.windlasbiotech.com

Key Facts

Market cap: R 690.77 Cr

Revenue (TTM): R 427.60 Cr

Earnings (TTM): R 15.74 Cr

Cash: R 54.26 Cr

Total Debt: R 31.32 Cr

Promoters' ownership: 59.95%

Liquidity: Low

52 Week range: R 312.50 - 452.10

Face value: R5.00

Shares outstanding: 2,17,94,375

10 Years Aggregate:

  • CFO: 93.55 Cr
  • EBITDA: 302.82 Cr
  • Net Profit: 166.76 Cr

Stock Performance

Time Period Windlas Biotech S&P BSE Healthcare S&P BSE Small Cap
YTD--15.5653.81
1 month-15.51-4.40-0.67
3 months---4.845.34
1 Year--27.4283.32
3 Years--21.6526.93
5 Years--8.8115.53
10 Years--15.2915.12
As on 25-Oct-2021